Analysts have recently evaluated Madrigal Pharmaceuticals and provided 12-month price targets. The average target is $497.5, accompanied by a high estimate of $554.00 and a low estimate of $428.00.

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025 investor letter ...

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has been approved in Europe for the treatment of metabolic ...

Vanderpump Rules' star Scheana Shay is reacting to Peter Madrigal saying that he doesn't like the former members of the show.

Madrigal Pharmaceuticals ( NASDAQ: MDGL) has received conditional marketing approval from the European Commission for ...

Defining workplace culture, elevating customer service and strengthening collaboration have been the name of the game for ...

Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

George Lopez, Jesse Garcia and Al Madrigal are among the new additions to the one-night-only virtual table read of the 2007 ...

New York; Tuesday, 7:10 p.m. EDT PITCHING PROBABLES: Phillies: Jesus Luzardo (12-6, 4.10 ERA, 1.30 WHIP, 170 strikeouts); Mets: Sean Manaea (1-2, 5.15 ERA, 1.12 WHIP, 45 strikeouts) BETMGM SPORTSBOOK ...

A true Austin institution since 1946, Sandy's Hamburgers is more than just a burger joint – it's a haven for classic frozen ...

BOTTOM LINE: The New York Mets will look to sweep a three-game series with a win against the Atlanta Braves. Atlanta has a 32 ...

Highlights,Madrigal Pharmaceuticals shows strong share movement in recent weeks,Revenue growth remains uneven across short- ...